| 3.9 |
15.5 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 3.2 |
9.5 |
GO:0090194 |
negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 2.9 |
14.5 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 2.8 |
8.5 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 2.8 |
8.3 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 2.7 |
8.1 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 2.3 |
4.6 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 2.3 |
6.8 |
GO:0060437 |
lung growth(GO:0060437) |
| 2.2 |
13.5 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 2.2 |
6.7 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 2.2 |
6.7 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) positive regulation of transforming growth factor beta3 production(GO:0032916) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 2.1 |
6.2 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 2.0 |
12.3 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 2.0 |
14.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.9 |
5.8 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 1.9 |
5.8 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 1.7 |
5.2 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 1.7 |
5.2 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.7 |
5.1 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 1.7 |
6.8 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 1.7 |
8.4 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 1.6 |
9.7 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 1.5 |
1.5 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 1.5 |
4.6 |
GO:1904706 |
response to cisplatin(GO:0072718) negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 1.5 |
13.6 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.5 |
21.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 1.5 |
7.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 1.4 |
4.3 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 1.4 |
6.9 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 1.4 |
5.5 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 1.3 |
5.3 |
GO:0060266 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 1.3 |
3.9 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 1.3 |
9.0 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 1.3 |
3.8 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 1.3 |
12.7 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 1.3 |
1.3 |
GO:0045472 |
response to ether(GO:0045472) |
| 1.3 |
6.3 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 1.2 |
3.5 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.2 |
3.5 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.1 |
2.3 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 1.1 |
7.9 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 1.1 |
4.4 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 1.1 |
4.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 1.1 |
3.2 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.1 |
3.2 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 1.1 |
8.6 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 1.1 |
2.1 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 1.1 |
3.2 |
GO:0035910 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 1.1 |
3.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.0 |
6.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 1.0 |
3.1 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 1.0 |
6.1 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 1.0 |
10.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 1.0 |
4.0 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 1.0 |
5.0 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 1.0 |
4.9 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 1.0 |
2.9 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.9 |
8.5 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.9 |
1.9 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.9 |
4.6 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.9 |
8.3 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.9 |
3.6 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.9 |
1.7 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.9 |
3.4 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
| 0.9 |
2.6 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.8 |
1.7 |
GO:1905065 |
positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.8 |
5.0 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.8 |
4.1 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.8 |
4.8 |
GO:0031126 |
snoRNA 3'-end processing(GO:0031126) |
| 0.8 |
0.8 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.8 |
3.9 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.8 |
7.9 |
GO:0061032 |
positive regulation of platelet activation(GO:0010572) visceral serous pericardium development(GO:0061032) |
| 0.8 |
3.1 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.8 |
2.3 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.8 |
3.9 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.8 |
3.0 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.8 |
3.0 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.8 |
3.8 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.7 |
2.2 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.7 |
3.0 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.7 |
5.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.7 |
2.9 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.7 |
2.2 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.7 |
2.9 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.7 |
8.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.7 |
4.7 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.7 |
4.6 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.6 |
2.6 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.6 |
3.2 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.6 |
5.1 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.6 |
1.9 |
GO:1903599 |
aggrephagy(GO:0035973) positive regulation of mitophagy(GO:1903599) |
| 0.6 |
7.0 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.6 |
3.8 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.6 |
9.3 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.6 |
1.2 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.6 |
7.9 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.6 |
2.4 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.6 |
3.0 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.6 |
2.4 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.6 |
1.8 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.6 |
1.8 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.6 |
2.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.6 |
7.4 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.6 |
3.3 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.6 |
3.9 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.6 |
1.7 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.5 |
1.1 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.5 |
12.4 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.5 |
5.8 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.5 |
2.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.5 |
1.1 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.5 |
5.2 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.5 |
2.6 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.5 |
3.5 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.5 |
0.5 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.5 |
3.0 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.5 |
1.0 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.5 |
1.5 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.5 |
2.5 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.5 |
1.5 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.5 |
6.0 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.5 |
1.0 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.5 |
1.4 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.5 |
9.5 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.5 |
3.3 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.5 |
2.3 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.5 |
2.7 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.4 |
1.3 |
GO:0032847 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of cellular pH reduction(GO:0032847) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.4 |
1.3 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.4 |
0.4 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.4 |
1.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.4 |
1.7 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.4 |
1.3 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.4 |
9.9 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.4 |
0.9 |
GO:0090670 |
RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
| 0.4 |
2.6 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.4 |
0.8 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.4 |
2.1 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.4 |
16.8 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.4 |
8.1 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.4 |
1.6 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.4 |
0.8 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.4 |
2.7 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.4 |
3.4 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.4 |
0.8 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 0.4 |
1.1 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.4 |
3.0 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.4 |
1.1 |
GO:0007521 |
muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
| 0.4 |
1.5 |
GO:1903898 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.4 |
3.4 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.4 |
1.1 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.4 |
1.9 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.4 |
1.5 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.4 |
8.4 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.4 |
4.4 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.4 |
5.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.4 |
2.2 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.4 |
1.1 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.4 |
2.1 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.4 |
0.7 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.3 |
1.4 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.3 |
1.4 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.3 |
2.1 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.3 |
6.1 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.3 |
1.3 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.3 |
0.7 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.3 |
2.3 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.3 |
1.0 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.3 |
1.3 |
GO:1904008 |
cellular response to salt(GO:1902075) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.3 |
1.6 |
GO:0031536 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) positive regulation of exit from mitosis(GO:0031536) |
| 0.3 |
1.3 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.3 |
1.3 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.3 |
2.9 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
| 0.3 |
2.2 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.3 |
3.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.3 |
10.6 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.3 |
0.9 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.3 |
0.9 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 |
4.7 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.3 |
0.9 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.3 |
3.9 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.3 |
2.1 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.3 |
0.9 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.3 |
2.6 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.3 |
2.3 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.3 |
7.5 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.3 |
0.6 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.3 |
1.4 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.3 |
4.0 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.3 |
3.1 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 |
0.8 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.3 |
1.7 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.3 |
0.8 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.3 |
0.8 |
GO:0010814 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.3 |
0.8 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 |
2.8 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.3 |
2.8 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.3 |
7.5 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.3 |
1.1 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.3 |
0.8 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.3 |
3.3 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.3 |
3.0 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.3 |
2.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.3 |
2.9 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 |
2.1 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 |
0.8 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 |
3.6 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.3 |
1.3 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
1.2 |
GO:0071205 |
clustering of voltage-gated potassium channels(GO:0045163) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.2 |
8.7 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
| 0.2 |
2.2 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.2 |
5.8 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.2 |
1.4 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.2 |
0.5 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.2 |
1.9 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 |
3.8 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 |
0.7 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
6.4 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
1.9 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.2 |
0.7 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.2 |
3.7 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.2 |
1.4 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.2 |
1.6 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.2 |
0.5 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.2 |
0.5 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
2.1 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 0.2 |
2.5 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.2 |
0.7 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.2 |
0.4 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.2 |
2.8 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.2 |
0.6 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.2 |
2.8 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.2 |
1.7 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
2.7 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.2 |
9.7 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.2 |
3.1 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.2 |
0.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
2.0 |
GO:0071281 |
cellular response to iron ion(GO:0071281) |
| 0.2 |
0.6 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 0.2 |
1.6 |
GO:1990144 |
intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.2 |
0.8 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
1.6 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.2 |
1.2 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.2 |
1.4 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 |
2.0 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.2 |
5.8 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
1.6 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.2 |
1.2 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.2 |
3.4 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.2 |
0.2 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.2 |
0.8 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.2 |
0.4 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) nitric oxide homeostasis(GO:0033484) |
| 0.2 |
2.1 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 |
0.9 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
0.6 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.2 |
0.6 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
11.2 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.2 |
1.3 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.2 |
0.5 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.2 |
2.3 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 |
5.2 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 |
14.9 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.2 |
0.5 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 |
2.4 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.2 |
0.3 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.2 |
0.7 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.2 |
6.6 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.2 |
1.5 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 |
0.5 |
GO:2000832 |
protein-chromophore linkage(GO:0018298) response to glucagon(GO:0033762) negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.2 |
0.5 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.2 |
0.6 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 |
1.9 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.2 |
4.4 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.2 |
0.8 |
GO:1902861 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) ferrous iron import(GO:0070627) copper ion import into cell(GO:1902861) |
| 0.2 |
0.8 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.2 |
1.0 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.2 |
6.6 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.2 |
4.4 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 |
0.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.2 |
2.2 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.2 |
0.8 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
0.5 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
0.8 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.2 |
0.9 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
0.6 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 0.1 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
0.6 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.1 |
0.7 |
GO:0048597 |
post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.1 |
2.9 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
7.3 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.3 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.1 |
3.9 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
0.4 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 |
0.7 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.6 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.4 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.1 |
1.4 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.1 |
2.2 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
1.5 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
0.5 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
0.5 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
5.0 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.3 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
0.8 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.9 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 |
1.5 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.3 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.1 |
3.8 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
1.0 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
1.4 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
0.4 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.1 |
0.3 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.8 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
2.0 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
1.6 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
1.7 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
1.9 |
GO:0043567 |
positive regulation of activated T cell proliferation(GO:0042104) regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
1.3 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
4.0 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.1 |
1.6 |
GO:0090177 |
establishment of planar polarity involved in neural tube closure(GO:0090177) |
| 0.1 |
1.8 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.7 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 |
2.3 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.1 |
0.4 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
0.2 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 |
0.8 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.9 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.1 |
2.2 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
3.5 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.1 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 |
6.2 |
GO:0051453 |
regulation of intracellular pH(GO:0051453) |
| 0.1 |
0.3 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
1.2 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
4.4 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
1.3 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.3 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
2.3 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.1 |
0.8 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.4 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
1.1 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.1 |
0.8 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.1 |
0.1 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
0.6 |
GO:0055012 |
ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.1 |
0.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
0.4 |
GO:0046684 |
response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
| 0.1 |
0.6 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
2.6 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.1 |
1.7 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.6 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 |
4.2 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.5 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.8 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.3 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 |
0.7 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.3 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil activation(GO:1902566) |
| 0.1 |
2.5 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.1 |
0.5 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.3 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.4 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.1 |
0.3 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.1 |
1.1 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.1 |
0.4 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.1 |
0.9 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.1 |
2.4 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
0.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
1.7 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
1.6 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.1 |
6.1 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.1 |
3.7 |
GO:0090305 |
nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.1 |
1.1 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.1 |
1.5 |
GO:0007091 |
metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) regulation of mitotic metaphase/anaphase transition(GO:0030071) metaphase/anaphase transition of cell cycle(GO:0044784) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.1 |
1.4 |
GO:0035196 |
production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
| 0.1 |
0.3 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
2.4 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.1 |
1.3 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.1 |
0.6 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.1 |
0.5 |
GO:0010717 |
regulation of epithelial to mesenchymal transition(GO:0010717) |
| 0.1 |
1.7 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.1 |
0.2 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) regulation of endothelial tube morphogenesis(GO:1901509) regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 |
1.4 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.1 |
0.2 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) regulation of potassium ion export(GO:1902302) |
| 0.1 |
0.5 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
0.8 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.1 |
0.4 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
1.8 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
0.9 |
GO:0007007 |
inner mitochondrial membrane organization(GO:0007007) |
| 0.1 |
0.7 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.1 |
0.1 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.1 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.1 |
1.8 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.5 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
3.3 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.1 |
0.1 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 |
0.2 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 |
0.3 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.1 |
0.1 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.2 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 |
0.9 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
0.8 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.5 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.1 |
0.5 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.3 |
GO:0090342 |
regulation of cell aging(GO:0090342) regulation of cellular senescence(GO:2000772) |
| 0.1 |
1.6 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
8.2 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.1 |
2.0 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.3 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.4 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
4.7 |
GO:2000045 |
regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.1 |
0.2 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
0.6 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
1.1 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 |
2.4 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 |
0.7 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 |
0.3 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 |
0.4 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
3.4 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.1 |
1.0 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.2 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.4 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.7 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.1 |
1.7 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.2 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.6 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
1.0 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.9 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.8 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
1.0 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.1 |
0.5 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
1.2 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.3 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
0.2 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.1 |
0.9 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 |
0.8 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.5 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.3 |
GO:0003056 |
regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.0 |
0.6 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.6 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.0 |
0.6 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.0 |
0.4 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.5 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.0 |
0.5 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.0 |
0.6 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.7 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.2 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.0 |
0.2 |
GO:0031509 |
chromatin remodeling at centromere(GO:0031055) pericentric heterochromatin assembly(GO:0031508) telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.0 |
0.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.0 |
0.2 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.0 |
0.2 |
GO:0090220 |
telomere localization(GO:0034397) meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.0 |
2.1 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
1.6 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
0.7 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.0 |
0.2 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.1 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.0 |
0.8 |
GO:0002092 |
positive regulation of receptor internalization(GO:0002092) |
| 0.0 |
0.6 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.0 |
0.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.8 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.4 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.0 |
0.1 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.0 |
1.4 |
GO:1904591 |
positive regulation of protein import(GO:1904591) |
| 0.0 |
0.6 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.2 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.0 |
0.1 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
2.3 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.3 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.9 |
GO:0034644 |
cellular response to UV(GO:0034644) |
| 0.0 |
0.3 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) regulation of epidermis development(GO:0045682) |
| 0.0 |
0.5 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.9 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.0 |
0.6 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.0 |
0.3 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.8 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.0 |
0.4 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.0 |
0.3 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.0 |
0.4 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.5 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.0 |
0.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.3 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
1.5 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.7 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
1.2 |
GO:0030177 |
positive regulation of Wnt signaling pathway(GO:0030177) |
| 0.0 |
0.0 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.0 |
0.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.0 |
0.7 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.0 |
0.3 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.0 |
1.6 |
GO:0098780 |
mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
0.3 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.1 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.1 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.0 |
0.1 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 |
0.0 |
GO:0033866 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 |
0.4 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.2 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.0 |
0.7 |
GO:0006457 |
protein folding(GO:0006457) |
| 0.0 |
0.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.0 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.4 |
GO:0006909 |
phagocytosis(GO:0006909) |
